Manage Your Liver
Q:

What is the difference between fatty liver disease, AFL, NAFLD, and NASH? What are their treatment options?

A:

Fatty liver is the accumulation of fat in liver cells. Fatty liver can be categorized into two types in general: alcoholic and nonalcoholic. Alcoholic fatty liver (AFL) is caused by excess consumption of alcohol and is usually reversible. [1] 

 

However, unlike alcoholic fatty liver, the cause for nonalcoholic fatty liver disease (NAFLD) is not clear. NAFLD is a spectrum of diseases that ranges from mild to severe. The mild form of NAFLD is also known as simple fatty liver; while the more severe form is called nonalcoholic steatohepatitis (NASH). 

 

NASH is characterized by buildup of fat in the liver, along with inflammation and liver damage. It is a serious condition as it has higher risk of advancing to cirrhosis and liver cancer. On the other hand, simple fatty liver generally does not cause great harm and most people do not have any symptoms. The ALT level of NASH patients are also usually more elevated than those with fatty liver. [2]

 

Currently, there is no specific treatment for alcoholic fatty liver. But if patients quit drinking and lead a healthy lifestyle, alcoholic fatty liver can usually be reversed. [1] There is also no conventional medical therapy to treat NAFLD or NASH. [2]

 

However, research papers on PubMed suggest that YHK, a natural alternative therapy, has an inhibitory effect on the development of NASH; it has been proven to effectively stop inflammation in the liver and help liver cells recover. A clinical study shows that NASH patients’ ALT values reduced to normal levels within 2 weeks of using YHK. [3][4][5]

 

Summary Table

 

Alcoholic Fatty Liver

NAFLD

NASH

Diagnosis

Usually diagnosed in asymptomatic patients who are undergoing evaluation for abnormal liver function tests. [6]

Liver biopsy – NAFLD or simple fatty liver is diagnosed if the tissue shows fat without inflammation and damage. [2]

Liver biopsy - NASH is diagnosed if the tissue shows fat along with inflammation and damage to liver cells. [2]

Progression

Alcoholic fatty liver (simple steatosis)

Alcoholic hepatitis

Alcohol-related cirrhosis

NASH

Cirrhosis

Liver cancer

Cirrhosis

Liver cancer

Treatment

Cease drinking

Reduce weight

YHK

Disclaimer:
  • * All research and clinical data should be used as reference purposes only, results may vary.
Tags:
Fatty liver diseaseAFLNAFLDNASHAlcoholic fatty livernonalcoholic steatohepatitis
Related Questions
A:
NASH is inflammation in the liver developed from accumulated fat in the organ, also known as fatty liver. NASH damages liver cells and liver function, which results in elevated ALT liver enzyme level.    As there are no approved treatments for NASH, the standard recommendation for patients is to lose weight only. However this doesn’t work for everyone so if you are struggling to find a way to stop NASH, please read on.   Wha
A:
There are between 10 to 15 million patients in the U.S. with NASH, and among these patients, one-fifth to one-fourth are at risk for cirrhosis or chronic liver damage.   The major characteristic of NASH is fat in the liver, along with inflammation and damage. NASH can be severe and can lead to cirrhosis. The number of NASH cirrhosis patients is currently on the rise, and it is predicted (NAFLD & NASH) to be the number 1 cause of liver transplants by 2020. [1] Ther
Hit Questions
A:
Research and developing our products has always been a big part of our work. Kyotsujigyo has worked with a number of well established organisations and universities in the past, including the University of Sao Paulo, GAIA Age-Management Foundation, The University of Western Ontario, University of Virginia, Yanaihara Research Institute,  Harada Hospital (Japan) and others.    In 2016 Kyotsujigyo has corporate with the National Key Research Institute in Hong K
A:
NASH is inflammation in the liver developed from accumulated fat in the organ, also known as fatty liver. NASH damages liver cells and liver function, which results in elevated ALT liver enzyme level.    As there are no approved treatments for NASH, the standard recommendation for patients is to lose weight only. However this doesn’t work for everyone so if you are struggling to find a way to stop NASH, please read on.   Wha
A:
In 2010, some 4.7 million people aged 65 years or older lived with Alzheimer's disease in the US.   Alzheimer’s is a common brain disease that causes progressive brain cell death that happens over a course of time. It will also cause a shrink in brain size as the tissue has progressively fewer nerve cells and connections. Alzheimer’s is thought to be caused by Protein Plaques building up in the brain cells, these Plaques are found between the dying cel
A:
There are between 10 to 15 million patients in the U.S. with NASH, and among these patients, one-fifth to one-fourth are at risk for cirrhosis or chronic liver damage.   The major characteristic of NASH is fat in the liver, along with inflammation and damage. NASH can be severe and can lead to cirrhosis. The number of NASH cirrhosis patients is currently on the rise, and it is predicted (NAFLD & NASH) to be the number 1 cause of liver transplants by 2020. [1] Ther
YHK Liver Therapy
Your Liver
Protection

starts here.
Buy YHK
Have Questions?
Sumbit your question to us for profeessional answers!
Have
Questions?
Sumbit your question
to us for profeessional answers!
YHK Liver Therapy
Your Liver
Protection

starts here.
Buy YHK
Looking for help? Ask our customer support team!
Contact Us